Zoetis ZTS Stock
Zoetis Price Chart
Zoetis ZTS Financial and Trading Overview
| Zoetis stock price | 71.41 USD |
| Previous Close | 69.1 USD |
| Open | 69.12 USD |
| Bid | 69.51 USD x 10000 |
| Ask | 69.65 USD x 30000 |
| Day's Range | 68.78 - 70.1 USD |
| 52 Week Range | 68.78 - 148.3 USD |
| Volume | 5.25M USD |
| Avg. Volume | 5.54M USD |
| Market Cap | 28.8B USD |
| Beta (5Y Monthly) | 0.729 |
| PE Ratio (TTM) | 11.368679 |
| EPS (TTM) | 6.08 USD |
| Forward Dividend & Yield | 2.12 (3.07%) |
| Ex-Dividend Date | July 20, 2026 |
| 1y Target Est | 96 USD |
ZTS Valuation Measures
| Enterprise Value | 36.38B USD |
| Trailing P/E | 11.368679 |
| Forward P/E | 10.648506 |
| PEG Ratio (5 yr expected) | 6.43 |
| Price/Sales (ttm) | 3.0233653 |
| Price/Book (mrq) | 8.890164 |
| Enterprise Value/Revenue | 3.819 |
| Enterprise Value/EBITDA | 8.947 |
Trading Information
Zoetis Stock Price History
| Beta (5Y Monthly) | 0.729 |
| 52-Week Change | -52.46% |
| S&P500 52-Week Change | 14.15% |
| 52 Week High | 148.3 USD |
| 52 Week Low | 68.78 USD |
| 50-Day Moving Average | 74.49 USD |
| 200-Day Moving Average | 98.61 USD |
ZTS Share Statistics
| Avg. Volume (3 month) | 5.54M USD |
| Avg. Daily Volume (10-Days) | 4.62M USD |
| Shares Outstanding | 413.22M |
| Float | 412.37M |
| Short Ratio | 3.76 |
| % Held by Insiders | 0.16% |
| % Held by Institutions | 100.32% |
| Shares Short | 17.39M |
| Short % of Float | 4.76% |
| Short % of Shares Outstanding | 4.20% |
Dividends & Splits
| Trailing Annual Dividend Rate | 2.06 |
| Trailing Annual Dividend Yield | 2.98% |
| 5 Year Average Dividend Yield | 95.00% |
| Payout Ratio | 0.3361 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | June 30, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 27.68% |
| Operating Margin (ttm) | 40.72% |
| Gross Margin | 71.73% |
| EBITDA Margin | 42.68% |
Management Effectiveness
| Return on Assets (ttm) | 15.35% |
| Return on Equity (ttm) | 64.91% |
Income Statement
| Revenue (ttm) | 9.53B USD |
| Revenue Per Share (ttm) | 22.14 USD |
| Quarterly Revenue Growth (yoy) | -0.20% |
| Gross Profit (ttm) | 6.83B USD |
| EBITDA | 4.07B USD |
| Net Income Avi to Common (ttm) | 2.64B USD |
| Diluted EPS (ttm) | 6.13 |
| Quarterly Earnings Growth (yoy) | -4.79% |
Balance Sheet
| Total Cash (mrq) | 1.68B USD |
| Total Cash Per Share (mrq) | 4.06 USD |
| Total Debt (mrq) | 9.26B USD |
| Total Debt/Equity (mrq) | 294 USD |
| Current Ratio (mrq) | 3.084 |
| Book Value Per Share (mrq) | 7.839 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 2.84B USD |
| Levered Free Cash Flow (ttm) | 2.02B USD |
Profile of Zoetis
| Country | United States |
| State | NJ |
| City | Parsippany |
| Address | 10 Sylvan Way |
| ZIP | 07054 |
| Phone | 973 822 7000 |
| Website | https://www.zoetis.com |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 14500 |
Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health solutions for the animal health industry in the United States and internationally. The company commercializes products primarily across companion animals comprising dogs, cats, and horses; and species, including livestock, such as cattle, swine, poultry, fish, and sheep. It also offers parasiticides, vaccines, dermatology, anti-infectives, pain and sedation, other pharmaceutical, and animal health diagnostics. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaborated with Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was incorporated in 2012 and is headquartered in Parsippany, New Jersey.
Q&A For Zoetis Stock
What is a current ZTS stock price?
Zoetis ZTS stock price today per share is 71.41 USD.
How to purchase Zoetis stock?
You can buy ZTS shares on the NYSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Zoetis?
The stock symbol or ticker of Zoetis is ZTS.
Which industry does the Zoetis company belong to?
The Zoetis industry is Drug Manufacturers - Specialty & Generic.
How many shares does Zoetis have in circulation?
The max supply of Zoetis shares is 413.22M.
What is Zoetis Price to Earnings Ratio (PE Ratio)?
Zoetis PE Ratio is 11.74506700 now.
What was Zoetis earnings per share over the trailing 12 months (TTM)?
Zoetis EPS is 6.08 USD over the trailing 12 months.
Which sector does the Zoetis company belong to?
The Zoetis sector is Healthcare.
Zoetis ZTS included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
|
|
{{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
S&P 500 INDEX
SPX
US
|
7773.95 USD — |
+0.66
|
3.48B USD — | — — | — — | — - | 3.48B USD — |
|
S&P 500 (Yahoo.com)
GSPC
US
|
7773.95 USD — |
+0.66
|
3.47B USD — | 7727.59 USD — | 7794.35 USD — | — - | 3.47B USD — |
|
NYSE Composite Index
NYA
US
|
23788.62 USD — |
+0.57
|
— — | — — | — — | — - | — — |
|
US Tech US Price Setters Index
NQPRCE
US
|
2989.47 USD — |
+0.95
|
— — | 2960.1 USD — | 2995.07 USD — | — - | — — |
|
US Tech DM Ex Japan Large Mid Ca
NQDMXJPLMAUD
US
|
2100.38 AUD 1467.26 USD |
<0.01
|
— — | 2100.38 AUD 1467.26 USD | 2100.38 AUD 1467.26 USD | — - | — — |
|
The Capital Strength Index
NQCAPST
US
|
3451.58 USD — |
+0.69
|
— — | 3415.43 USD — | 3454.91 USD — | — - | — — |
|
NYSE Arca Pharmaceutical Index
DRG
US
|
1206.02 USD — |
-0.56
|
— — | — — | — — | — - | — — |
|
US Tech US Smart Pharmaceuticals
NQSSPH
US
|
2165.05 USD — |
+0.18
|
— — | 2142.41 USD — | 2173.76 USD — | — - | — — |
|
US Tech AlphaDEX Multi Cap Growt
NQDXUSMLTCG
US
|
3961.48 USD — |
+0.43
|
— — | 3927.78 USD — | 3975.5 USD — | — - | — — |
|
The Capital Strength Net Total
NQCAPSTN
US
|
4137.1 USD — |
+0.69
|
— — | 4093.77 USD — | 4141.11 USD — | — - | — — |
- {{ link.label }} {{link}}
